- Investing Ideas
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
54
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
54 companies
Swedish Orphan Biovitrum
Market Cap: SEK 140.4b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 406.20
7D
1.3%
1Y
59.8%
Camurus
Market Cap: SEK 30.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 514.50
7D
6.4%
1Y
-5.4%
AddLife
Market Cap: SEK 18.8b
Provides equipment, consumables, and reagents primarily to medical care, research, colleges and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 154.20
7D
8.6%
1Y
6.6%
Bonesupport Holding
Market Cap: SEK 15.3b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 229.80
7D
7.3%
1Y
-21.2%
Vitrolife
Market Cap: SEK 13.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 96.70
7D
4.3%
1Y
-36.3%
BioGaia
Market Cap: SEK 12.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 120.00
7D
2.7%
1Y
22.0%
MedCap
Market Cap: SEK 7.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 486.80
7D
2.5%
1Y
35.6%
Swedencare
Market Cap: SEK 4.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 27.40
7D
8.7%
1Y
-22.3%
Vicore Pharma Holding
Market Cap: SEK 2.8b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 9.97
7D
-2.1%
1Y
55.8%
Egetis Therapeutics
Market Cap: SEK 2.4b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 6.01
7D
1.9%
1Y
59.4%
Flerie
Market Cap: SEK 2.3b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 28.80
7D
-3.0%
1Y
-28.5%
Saniona
Market Cap: SEK 2.1b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 15.21
7D
-7.0%
1Y
126.3%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 22.80
7D
-0.9%
1Y
-15.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.80
7D
1.9%
1Y
6.8%
BICO Group
Market Cap: SEK 1.3b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 18.08
7D
5.4%
1Y
-49.0%
Devyser Diagnostics
Market Cap: SEK 1.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 76.00
7D
-1.7%
1Y
-12.6%
Xspray Pharma
Market Cap: SEK 1.3b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 30.25
7D
8.0%
1Y
1.7%
Cantargia
Market Cap: SEK 974.6m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 3.92
7D
-2.7%
1Y
201.5%
FluoGuide
Market Cap: SEK 632.7m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 38.70
7D
2.7%
1Y
-5.4%
Oncopeptides
Market Cap: SEK 534.4m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.35
7D
-3.4%
1Y
-30.8%
Sprint Bioscience
Market Cap: SEK 386.2m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 3.66
7D
46.4%
1Y
470.1%
Ascelia Pharma
Market Cap: SEK 376.8m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.97
7D
2.4%
1Y
8.4%
Mendus
Market Cap: SEK 306.7m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.00
7D
12.6%
1Y
4.2%
Elicera Therapeutics
Market Cap: SEK 274.2m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 5.65
7D
3.9%
1Y
84.6%
Diamyd Medical
Market Cap: SEK 221.9m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 1.43
7D
0.8%
1Y
-81.9%
Isofol Medical
Market Cap: SEK 193.1m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.69
7D
2.1%
1Y
-61.4%
SenzaGen
Market Cap: SEK 168.4m
Provides non-animal tests for assessing allergenicity.
SENZA
SEK 5.18
7D
0.8%
1Y
18.5%
KDventures
Market Cap: SEK 167.8m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDV B
SEK 0.25
7D
-0.8%
1Y
-69.9%
Xbrane Biopharma
Market Cap: SEK 153.3m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 7.44
7D
6.4%
1Y
-69.8%
IRLAB Therapeutics
Market Cap: SEK 132.5m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other central nervous system (CNS) disorders in the United States.
IRLAB A
SEK 1.56
7D
9.4%
1Y
-77.8%
Subgen AI
Market Cap: SEK 128.3m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.13
7D
-21.7%
1Y
n/a
Biovica International
Market Cap: SEK 112.1m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.38
7D
9.7%
1Y
-45.1%
Annexin Pharmaceuticals
Market Cap: SEK 96.7m
A clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 13.70
7D
2.2%
1Y
-49.6%
Alzinova
Market Cap: SEK 91.4m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.59
7D
-1.7%
1Y
-68.4%
Vivesto
Market Cap: SEK 85.7m
Develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.077
7D
-2.0%
1Y
-67.3%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%